Akzo Nobel NV
Akzo Nobel NV is a global leader in paints and specialty chemicals, generating revenue primarily through the sale of coatings, performance chemicals, and functional materials.
Business. Akzo Nobel NV (AKZO.AS) is a Dutch company headquartered in the Netherlands and primarily listed on the Euronext Amsterdam. The firm operates within the Basic Materials sector, specifically focusing on the Commodity Chemicals industry. It engages in the production and sale of chemicals, generating revenue through volume-based commodity grades and specialty premiums for branded formulations. Specific operating segments and geographic breakdowns are not provided in the available data.
Analyst recommendations
19 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
1Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Akzo Nobel NV (AKZO.AS) is a Dutch company headquartered in the Netherlands and primarily listed on the Euronext Amsterdam. The firm operates within the Basic Materials sector, specifically focusing on the Commodity Chemicals industry. It engages in the production and sale of chemicals, generating revenue through volume-based commodity grades and specialty premiums for branded formulations. Specific operating segments and geographic breakdowns are not provided in the available data.
Akzo Nobel's capital structure is characterized by a debt-to-equity ratio of 1.21, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.1 and negative free cash flow of -64 million EUR, suggesting potential short-term liquidity constraints. Despite holding 1.17 billion EUR in cash and equivalents, the company's long-term debt of 5.42 billion EUR offsets this, resulting in a net cash position that is negative after subtracting total debt.
Profitability metrics for Akzo Nobel show a return on equity (ROE) of 3.96% and a return on assets (ROA) of 1.22%, both of which are below the industry median for Commodity Chemicals. The company's operating margin is 9.7%, which is also below the median for its industry, indicating that it is underperforming in terms of converting revenue into operating profit.
Geographically, Akzo Nobel's revenue is concentrated in Europe, with a significant portion derived from its Paints and Coatings segment. The company's exposure to emerging markets is limited, and its revenue concentration in a few key regions could pose a risk in the event of regional economic downturns or geopolitical instability.
Akzo Nobel's growth trajectory is modest, with revenue of 2.78 billion EUR in the latest reporting period. The company's capital expenditures of -115 million EUR suggest a reduction in investment in new projects or facilities, which could impact long-term growth potential. Analysts have provided a mean price target of 61.75 EUR, with a median of 63.00 EUR, indicating a generally positive outlook despite the company's current financial challenges.
Risk factors for Akzo Nobel include its high debt load and negative free cash flow, which could limit its ability to invest in growth opportunities or withstand economic downturns. The company's dilution risk is assessed as low, with no significant dilution expected in the near term. However, the company's reliance on debt financing and its exposure to volatile commodity prices could increase financial risk in the future.
Recent events for Akzo Nobel include the release of its latest financial results, which show a decline in operating cash flow and free cash flow. The company has also announced plans to reduce capital expenditures in the coming year, which could impact its ability to maintain or grow its market share. Analysts have provided a range of price targets, with a mean of 61.75 EUR and a median of 63.00 EUR, indicating a generally positive outlook despite the company's current financial challenges.
- Akzo Nobel's debt-to-equity ratio of 1.21 indicates a moderate reliance on debt financing.
- The company's ROE of 3.96% and ROA of 1.22% are below the industry median, suggesting underperformance in profitability.
- Revenue is concentrated in Europe, with limited exposure to emerging markets.
- Analysts have provided a generally positive outlook, with a mean price target of 61.75 EUR.
- The company's liquidity position is assessed as medium, with a current ratio of 1.1 and negative free cash flow.
Bull / Bear case
Generated · model-assistedOperating income surged 22.1% year-over-year to EUR 1.14 billion, demonstrating strong operational leverage despite revenue headwinds.
Analysts project 6.9% upside to a mean price target of EUR 61.75, reflecting positive market sentiment.
Return on equity of 3.96% outperforms the cohort median of 3.61%, showing efficient capital utilization.
Free cash flow improved 12.5% year-over-year to EUR 359 million, supporting potential dividend or buyback capacity.
Debt-to-equity ratio of 1.21 places the company in the bottom quartile of its cohort, signaling high leverage risk.
Revenue declined 5.2% year-over-year to EUR 10.16 billion, indicating weakening top-line growth momentum.
The company faces high credit risk, which could increase borrowing costs and limit financial flexibility.
Cash conversion of -0.13 is in the bottom quartile of the cohort, suggesting poor cash generation relative to earnings.
Net income CAGR of -6.4% over four years highlights a long-term trend of declining profitability.
In focus — financials by report
Revenue €2.39B, −8,7% YoY; Operating income −7,8% YoY.
- ▍Revenue €2.39B, −8,7% YoY
- ▍Operating income −7,8% YoY
- ▍Net income −13,1% YoY
- ▍Free cash flow −3,6% YoY
- ▍Net margin 3.9%
Revenue €2.37B, −9,4% YoY; Operating income +435,9% YoY.
- ▍Revenue €2.37B, −9,4% YoY
- ▍Operating income +435,9% YoY
- ▍Net income +2 747,6% YoY
- ▍Free cash flow +731,3% YoY
- ▍Net margin 25.2%
Revenue €2.55B, −4,5% YoY; Operating income −111,2% YoY.
- ▍Revenue €2.55B, −4,5% YoY
- ▍Operating income −111,2% YoY
- ▍Net income −219,0% YoY
- ▍Free cash flow −202,7% YoY
- ▍Net margin -7.6%
Revenue €2.63B, −5,7% YoY; Operating income −20,7% YoY.
- ▍Revenue €2.63B, −5,7% YoY
- ▍Operating income −20,7% YoY
- ▍Net income −29,9% YoY
- ▍Free cash flow −78,1% YoY
- ▍Net margin 4.7%
Revenue €2.61B; Operating income €192.0M.
- ▍Revenue €2.61B
- ▍Operating income €192.0M
- ▍Net margin 4.1%
Revenue €2.62B; Operating income €142.0M.
- ▍Revenue €2.62B
- ▍Operating income €142.0M
- ▍Net margin 0.8%
Revenue €2.67B; Operating income €259.0M.
- ▍Revenue €2.67B
- ▍Operating income €259.0M
- ▍Net margin 6.1%
Revenue €2.78B; Operating income €270.0M.
- ▍Revenue €2.78B
- ▍Operating income €270.0M
- ▍Net margin 6.4%
Revenue €10.16B, −5,2% YoY; Operating income +22,1% YoY.
- ▍Revenue €10.16B, −5,2% YoY
- ▍Operating income +22,1% YoY
- ▍Net income +17,2% YoY
- ▍Free cash flow +12,5% YoY
- ▍Net margin 6.3%
Revenue €10.71B, +0,4% YoY; Operating income −5,2% YoY.
- ▍Revenue €10.71B, +0,4% YoY
- ▍Operating income −5,2% YoY
- ▍Net income +22,6% YoY
- ▍Free cash flow +67,0% YoY
- ▍Net margin 5.1%
Revenue €10.67B, −1,6% YoY; Operating income +38,8% YoY.
- ▍Revenue €10.67B, −1,6% YoY
- ▍Operating income +38,8% YoY
- ▍Net income +25,6% YoY
- ▍Free cash flow +124,7% YoY
- ▍Net margin 4.1%
Revenue €10.85B, +13,1% YoY; Operating income −36,7% YoY.
- ▍Revenue €10.85B, +13,1% YoY
- ▍Operating income −36,7% YoY
- ▍Net income −57,5% YoY
- ▍Free cash flow −84,0% YoY
- ▍Net margin 3.2%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 3,83 |
| Revenue | —no estimate | —no estimate | 10,0B EUR |
| Operating income | —no estimate | —no estimate | 1,0B EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Akzo Nobel NV Market data — financials · 2026-05-27
- Akzo Nobel NV Market data — analyst estimates · 2026-05-27
- Akzo Nobel NV Market data — ESG · 2026-05-27
Ownership & reference
Leadership
- Jeff JirakMember of the Management Board